MBody AI Ltd. (MBAI)
NCM · Technology · Software - Infrastructure
$2.04
+13.61%
Closing price as of 2026-10-28 · Source: TEK2day Finance
Key Metrics
Market Cap
$31.3M
Shares Outstanding
15.3M
Exchange
NCM
Currency
USD
About MBody AI Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (20.0M) | (17.8M) | (9.5M) | (2.4M) |
| Net Income | (19.1M) | (17.6M) | (25.1M) | 4.1M |
| Diluted EPS | $-3.37 | $-3.00 | $-4.30 | $0.66 |